3rd Annual Cell and Gene Therapy Congress
November 06, 2017 ‐ November 07, 2017 in London, UK
The 3rd annual Cell and Gene Therapy congress will be held on November 6 and 7, 2017 in London, UK.
David Sourdive, Ph.D., Executive Vice President Technical Operations at Cellectis, to take part in this event on November the 7th from 9:30 AM and 10:00 AM with a presentation entitled "Leveraging TALEN®-gene edited CAR-T platform to industrialize off-the-shelf allogeneic cell-based pharmaceuticals."